Hypoallergenicity of a Hydrolyzed Protein Infant Formula

NCT05731206 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2024-05-08

No results posted yet for this study

Summary

Study to demonstrate hypoallergenicity of a hydrolysed protein infant formula in a population of children with confirmed cow's milk allergy.

Conditions

  • Cow's Milk Allergy

Interventions

OTHER

Hydrolyzed protein infant formula

Hydrolyzed protein infant formula

OTHER

commercially available hypoallergenic infant formula

commercially available hypoallergenic infant formula

Sponsors & Collaborators

  • Nutricia Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
0 Days
Max Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2026-12-31
Completion
2027-03-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05731206 on ClinicalTrials.gov